Important monitoring includes: Blood sugar levels Regular glucose monitoring, especially for diabetes patients
It has been observed that repeated doses of DCA resulted in loss of GSTZ1-1 protein and activity, probably due to post-translationally modifications of the enzyme 85
According to a recent report by Morgan Stanley, the global market for obesity drugs is expected to increase 15-fold by 2030, driven by their expanding use beyond weight loss to address various obesity-related conditions
Studies emphasize that treating obesity as a chronic metabolic condition, rather than relying solely on lifestyle changes, is essential
Most payers evaluate any drug of any drug class based on safety, efficacy and cost, he said
Differences: Duration of Action: Short-acting GLP-1RAs (e.g., exenatide twice daily or lixisenatide) act by primarily delaying gastric emptying